DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Revlimid (Lenalidomide) - White Blood Cell Count Decreased - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with White Blood Cell Count Decreased (399)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Revlimid (Lenalidomide) where reactions include white blood cell count decreased. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 399   Next >>

Possible Revlimid side effects in female

Reported by a physician from Japan on 2012-08-21

Patient: female

Reactions: Mania, White Blood Cell Count Decreased, Hepatic Function Abnormal, Neutrophil Count Decreased

Drug(s) suspected as cause:
Dexamethasone Acetate
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2010-10-18
    End date: 2010-11-06

Revlimid
    Dosage: 25 milligram
    Administration route: Oral
    Start date: 2010-11-15
    End date: 2010-11-17

Revlimid
    Dosage: 15 milligram
    Administration route: Oral
    Start date: 2011-01-26
    End date: 2011-02-15

Revlimid
    Dosage: 15 milligram
    Administration route: Oral
    Start date: 2011-04-06
    End date: 2011-04-26

Revlimid
    Dosage: 25 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2010-10-18
    End date: 2010-11-07

Revlimid
    Dosage: 15 milligram
    Administration route: Oral
    Start date: 2010-12-29
    End date: 2011-01-18

Revlimid
    Dosage: 15 milligram
    Administration route: Oral
    Start date: 2010-12-01
    End date: 2010-12-21

Other drugs received by patient: Promac; Itraconazole; Sulfamethoxazole and Trimethoprim; BIO-Three; Allopurinol



Possible Revlimid side effects in 33 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-20

Patient: 33 year old male, weighing 123.0 kg (270.6 pounds)

Reactions: Abdominal Pain, Weight Decreased, Blood Bilirubin Increased, Headache, Oesophagitis, Hypocalcaemia, Blood Creatinine Increased, Stomatitis, Hyperglycaemia, Hypotension, Small Intestinal Obstruction, Aspartate Aminotransferase Increased, Platelet Count Decreased, Rash Maculo-Papular, Neutrophil Count Decreased, Graft Versus Host Disease, Pain, Somnolence, Gastritis, Ileus, Dizziness, Sinusitis, Gastrooesophageal Reflux Disease, Renal Failure Acute, White Blood Cell Count Decreased, Vomiting, Nausea, Alanine Aminotransferase Increased, Atrial Fibrillation, Hyponatraemia, Facial Pain, Eye Pain, Hypophosphataemia, Syncope, Diarrhoea, Hypoalbuminaemia, Skin Infection, Sinus Tachycardia, Large Intestinal Haemorrhage

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Revlimid

Other drugs received by patient: Caspofungin Acetate



Possible Revlimid side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-20

Patient: female

Reactions: Drug Dose Omission, White Blood Cell Count Decreased, Dyspnoea, Osteoporosis, Rash, Diarrhoea, Dysphonia, Pulmonary Congestion, Memory Impairment, Lymphoedema

Drug(s) suspected as cause:
Revlimid
    Dosage: 15 milligram
    Administration route: Oral
    Start date: 2009-12-01
    End date: 2010-01-01

Revlimid
    Dosage: 25 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2009-01-01

Revlimid
    Dosage: 15 milligram
    Administration route: Oral
    Start date: 2011-09-01

Revlimid
    Dosage: 15 milligram
    Administration route: Oral
    Start date: 2012-05-01



Possible Revlimid side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-10

Patient: male

Reactions: White Blood Cell Count Decreased, Haemorrhage, Platelet Count Decreased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Revlimid

Other drugs received by patient: Prochlorperazine Maleate; Hydrocortisone; Tylenol (Caplet)



Possible Revlimid side effects in female

Reported by a physician from Japan on 2012-08-07

Patient: female

Reactions: Hepatic Function Abnormal, Pain, Constipation, Multi-Organ Failure, Upper Respiratory Tract Infection, Hypoxia, Lymphocyte Count Decreased, Decreased Appetite, White Blood Cell Count Decreased, Pneumonia, LIP DRY, Restlessness, Anaemia, Cardiac Failure, Depressed Level of Consciousness, Platelet Count Decreased, Bronchitis, Neutrophil Count Decreased

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Dexamethasone Acetate
    Dosage: 40 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2011-01-12
    End date: 2011-01-12

Revlimid
    Dosage: 15 milligram
    Administration route: Oral
    Start date: 2010-12-01
    End date: 2010-12-21

Revlimid
    Dosage: 10 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2010-09-28
    End date: 2010-10-20

Revlimid
    Dosage: 15 milligram
    Administration route: Oral
    Start date: 2011-01-05
    End date: 2011-01-18

Revlimid
    Dosage: 15 milligram
    Administration route: Oral
    Start date: 2010-11-04
    End date: 2010-11-23

Other drugs received by patient: Zometa; Decadron Phosphate; Depas; Aspirin; Risperdal; Zometa; Decadron Phosphate; Zometa; Omeprazole; Prednisolone; Prednisolone; Depas; Ventolin; Decadron Phosphate; Prednisolone; Decadron Phosphate; Decadron Phosphate; Famotidine



Possible Revlimid side effects in female

Reported by a physician from Japan on 2012-07-31

Patient: female, weighing 34.5 kg (75.9 pounds)

Reactions: White Blood Cell Count Decreased, Urinary Tract Infection, Febrile Neutropenia, Multiple Myeloma, Neutrophil Count Decreased, Hypertension

Adverse event resulted in: death, disablity

Drug(s) suspected as cause:
Decadron
    Dosage: 6.6mg x 2
    Start date: 2010-10-30
    End date: 2010-11-02

Decadron
    Dosage: 1.65g x 1
    Start date: 2010-10-30
    End date: 2010-11-02

Decadron
    Dosage: 6.6mg x 5
    Start date: 2010-10-10
    End date: 2010-10-13

Decadron
    Dosage: 6.6mg x 5
    Indication: Multiple Myeloma
    Start date: 2010-10-02
    End date: 2010-10-05

Revlimid
    Dosage: 10 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2010-10-02
    End date: 2010-10-22

Revlimid
    Dosage: 15 milligram
    Administration route: Oral
    Start date: 2010-11-27
    End date: 2010-12-02

Revlimid
    Dosage: 10 milligram
    Administration route: Oral
    Start date: 2010-10-30
    End date: 2010-11-19

Other drugs received by patient: Omeprazole; Lasix; Fentanyl-100; Lasix; Orgaran; Loxonin; Neophyllin



Possible Revlimid side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-18

Patient: male

Reactions: White Blood Cell Count Decreased, Haemorrhage, Platelet Count Decreased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Revlimid

Other drugs received by patient: Prochlorperazine Maleate; Tylenol (Caplet); Hydrocortisone



Possible Revlimid side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-16

Patient: male, weighing 111.2 kg (244.7 pounds)

Reactions: White Blood Cell Count Decreased

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Revlimid

Other drugs received by patient: Levemir; Temazepam; Ativan; Metolazone; Nucynta; Protonix; Neurontin; Oxycodone HCL; Leukine; Novolog; Metoprolol Tartrate; Prednisone; Carafate; Potassium Chloride; Ranitidine; Xarelto; Compazine; Levothyroxine Sodium; Reglan



Possible Revlimid side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-16

Patient: female

Reactions: White Blood Cell Count Decreased, Dysphagia, Hot Flush, Nausea, Diarrhoea, Chills

Drug(s) suspected as cause:
Revlimid

Other drugs received by patient: Synthroid



Possible Revlimid side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-10

Patient:

Reactions: Confusional State, Hypoglycaemia, Blood Albumin Decreased, Acidosis, Prothrombin Time Prolonged, Blood Fibrinogen Decreased, Oedema Peripheral, Blood Creatinine Increased, Renal Failure Acute, White Blood Cell Count Decreased, Blood Alkaline Phosphatase Increased, International Normalised Ratio Increased, Hypotension, Haemoglobin Decreased, Sepsis, Platelet Count Decreased, Neutrophil Count Decreased

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Decadron
    Dosage: 20 mg, qw
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2010-07-31
    End date: 2010-08-28

Decadron
    Dosage: 12 mg, qd
    Administration route: Oral
    Start date: 2010-11-12
    End date: 2010-11-15

Revlimid
    Dosage: 25 mg, qd
    Indication: Multiple Myeloma
    Start date: 2010-08-15

Other drugs received by patient: Alkeran



Possible Revlimid side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-02

Patient: female, weighing 95.2 kg (209.4 pounds)

Reactions: Confusional State, Hypoglycaemia, Blood Albumin Decreased, Prothrombin Time Prolonged, Acidosis, Blood Fibrinogen Decreased, Oedema Peripheral, Blood Creatinine Increased, Renal Failure Acute, Blood Alkaline Phosphatase Increased, White Blood Cell Count Decreased, International Normalised Ratio Increased, Hypotension, Haemoglobin Decreased, Sepsis, Platelet Count Decreased, Neutrophil Count Decreased

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Alkeran
    Dosage: 14 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2010-11-12
    End date: 2010-11-15

Decadron
    Dosage: 20 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2010-07-31
    End date: 2010-08-28

Decadron
    Dosage: 12 milligram
    Administration route: Oral
    Start date: 2010-11-12
    End date: 2010-11-15

Revlimid
    Dosage: 25 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2010-08-15
    End date: 2010-08-30



Possible Revlimid side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-28

Patient: female, weighing 60.8 kg (133.8 pounds)

Reactions: White Blood Cell Count Decreased, Drug Dose Omission, Cardiac Flutter, Blood Glucose Abnormal, Tremor, Blood Calcium Decreased, Renal Impairment, Dyspepsia, RED Blood Cell Count Decreased, Dehydration

Drug(s) suspected as cause:
Revlimid
    Dosage: 5 milligram
    Administration route: Oral
    Start date: 2012-02-01

Revlimid
    Dosage: 15 milligram
    Administration route: Oral
    Start date: 2010-10-05
    End date: 2011-05-26

Revlimid
    Dosage: 10 milligram
    Administration route: Oral
    Start date: 2012-01-11



Possible Revlimid side effects in male

Reported by a physician from United States on 2012-06-26

Patient: male, weighing 92.2 kg (202.8 pounds)

Reactions: White Blood Cell Count Decreased, Dysgeusia, Diarrhoea, Platelet Count Decreased, Pancytopenia, Hyperthyroidism

Drug(s) suspected as cause:
Revlimid
    Dosage: 10 milligram
    Administration route: Oral
    Start date: 2012-05-01

Revlimid
    Dosage: 15 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2011-10-05

Other drugs received by patient: Losartan Potassium and Hydrochlorothiazide; Pentamidine Isethionate; Coumadin; Coumadin; Niacin; Coumadin; Ibuprofen; Aspirin; Calcium + Vitamin D; Ascorbic Acid; Lovenox; Avodart; Synthroid



Possible Revlimid side effects in 33 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-25

Patient: 33 year old male, weighing 123.0 kg (270.6 pounds)

Reactions: Blood Bilirubin Increased, Abdominal Pain, Weight Decreased, Headache, Oesophagitis, Hypocalcaemia, Blood Creatinine Increased, Stomatitis, Hypotension, Hyperglycaemia, Intestinal Obstruction, Aspartate Aminotransferase Increased, Platelet Count Decreased, Rash Maculo-Papular, Neutrophil Count Decreased, Pain, Somnolence, Gastritis, Ileus, Dizziness, Gastrooesophageal Reflux Disease, Sinusitis, Renal Failure Acute, White Blood Cell Count Decreased, Vomiting, Nausea, Alanine Aminotransferase Increased, Hyponatraemia, Atrial Fibrillation, Facial Pain, Eye Pain, Hypophosphataemia, Syncope, Diarrhoea, Hypoalbuminaemia, Skin Infection, Sinus Tachycardia, Large Intestinal Haemorrhage

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Revlimid



Possible Revlimid side effects in female

Reported by a physician from United States on 2012-06-22

Patient: female

Reactions: White Blood Cell Count Decreased, Pneumonia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Revlimid
    Dosage: 10 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2006-07-01

Revlimid
    Dosage: 10 milligram
    Administration route: Oral
    Start date: 2011-04-10

Revlimid
    Dosage: 10 milligram
    Administration route: Oral
    Start date: 2010-11-01
    End date: 2011-03-30

Other drugs received by patient: Arimidex; Bactrim DS; Zometa; Senokot; Zinc Sulfate; Folic Acid; Levaquin; Aspirin; Vitamin B6; Zithromax; Prednisone TAB; Acyclovir



Possible Revlimid side effects in female

Reported by a physician from United States on 2012-06-22

Patient: female

Reactions: White Blood Cell Count Decreased, Pneumonia, Pancytopenia, Multiple Myeloma, Neutropenia

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Revlimid
    Dosage: 25 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2010-06-01
    End date: 2010-11-01

Revlimid
    Dosage: 25 milligram
    Administration route: Oral
    Start date: 2011-01-01
    End date: 2011-07-01

Revlimid
    Dosage: 10 milligram
    Administration route: Oral
    Start date: 2011-09-01
    End date: 2011-12-29

Revlimid
    Dosage: 15 milligram
    Administration route: Oral
    Start date: 2011-08-01
    End date: 2011-09-01



Possible Revlimid side effects in female

Reported by a physician from United States on 2012-06-20

Patient: female

Reactions: White Blood Cell Count Decreased, Multiple Myeloma, Neutropenia

Adverse event resulted in: death, life threatening event

Drug(s) suspected as cause:
Revlimid
    Dosage: 15 milligram
    Administration route: Oral
    Start date: 2011-08-01

Revlimid
    Dosage: 10 milligram
    Administration route: Oral
    Start date: 2011-09-01
    End date: 2011-12-29

Revlimid
    Dosage: 25 milligram
    Administration route: Oral
    Start date: 2011-01-01

Revlimid
    Dosage: 25 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2010-06-01



Possible Revlimid side effects in female

Reported by a physician from United States on 2012-06-18

Patient: female

Reactions: White Blood Cell Count Decreased, Pneumonia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Revlimid
    Dosage: 10 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2006-07-01

Revlimid
    Dosage: 10 milligram
    Administration route: Oral
    Start date: 2010-11-01
    End date: 2011-03-30

Revlimid
    Dosage: 10 milligram
    Administration route: Oral
    Start date: 2011-04-10

Other drugs received by patient: Aspirin; Zinc Sulfate; Prednisone; Bactrim DS; Senokot; Levaquin; Zithromax; Zometa; Arimidex; Vitamin B6; Folic Acid; Acyclovir



Possible Revlimid side effects in female

Reported by a physician from United States on 2012-06-15

Patient: female

Reactions: White Blood Cell Count Decreased, Breast Cancer

Drug(s) suspected as cause:
Revlimid
    Dosage: 25 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2008-09-01

Revlimid
    Dosage: 10 milligram
    Administration route: Oral
    Start date: 2008-11-01

Revlimid
    Dosage: 15 milligram
    Administration route: Oral
    Start date: 2009-04-01

Other drugs received by patient: Chemotherapy



Possible Revlimid side effects in female

Reported by a physician from United States on 2012-06-11

Patient: female, weighing 94.8 kg (208.6 pounds)

Reactions: White Blood Cell Count Decreased, Dyspnoea, Asthenia, Full Blood Count Decreased

Drug(s) suspected as cause:
Revlimid



Possible Revlimid side effects in 65 year old male

Reported by a physician from United States on 2012-05-31

Patient: 65 year old male

Reactions: White Blood Cell Count Decreased, Neutropenia

Drug(s) suspected as cause:
Alkeran
    Dosage: 18mg at night
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2011-05-25
    End date: 2011-05-28

Revlimid
    Dosage: 15mg cyclic
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2011-03-01
    End date: 2011-06-01

Other drugs received by patient: Prednisone



Possible Revlimid side effects in male

Reported by a health professional (non-physician/pharmacist) from Italy on 2012-05-30

Patient: male

Reactions: White Blood Cell Count Decreased, Back Pain, Night Sweats, Chills, Lymphopenia, Pyrexia, Pneumocystis Jiroveci Pneumonia, Platelet Count Decreased, Neutropenia, Asthenia, Muscle Spasms

Adverse event resulted in: death

Drug(s) suspected as cause:
Revlimid
    Dosage: 25 milligram
    Administration route: Oral
    Indication: Lymphoma
    Start date: 2008-12-30
    End date: 2009-01-20

Revlimid
    Dosage: 15 milligram
    Administration route: Oral
    Start date: 2009-02-04
    End date: 2009-09-14

Other drugs received by patient: Acesistem; Coumadin; Rituximab; Nicetile; Unoprost



Possible Revlimid side effects in female

Reported by a physician from United States on 2012-05-25

Patient: female

Reactions: White Blood Cell Count Decreased, Convulsion

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Revlimid
    Dosage: 15 milligram
    Administration route: Oral
    Start date: 2012-04-01

Revlimid
    Dosage: 25 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2012-02-06

Other drugs received by patient: Zometa; Antibiotics; Calcium; Vitamin D; Aspirin



Possible Revlimid side effects in male

Reported by a consumer/non-health professional from United States on 2012-05-24

Patient: male

Reactions: White Blood Cell Count Decreased, Diplopia, Blindness Transient

Drug(s) suspected as cause:
Revlimid
    Dosage: 5 milligram
    Administration route: Oral
    Start date: 2011-07-01

Revlimid
    Dosage: 10 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2011-03-01
    End date: 2011-07-01

Other drugs received by patient: Oxycontin; Oxycontin; Lipitor; Aspirin; Citalopram Hydrobromide; Acyclovir



Possible Revlimid side effects in 64 year old female

Reported by a physician from United States on 2012-05-23

Patient: 64 year old female

Reactions: White Blood Cell Count Decreased, Diverticulitis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Revlimid

Other drugs received by patient: Aspirin; Calcium Ascorbate (Calcium Ascorbate); Centrum Silver (Centrum Silver); Biotin (Biotin) (Enteric-Coated Tablet); Glipizide ER (Glipizide); Metformin HCL; Prochlorperazine Maleate (Prochlorperazine Maleate); Metamucil (Metamucil ^procter + Gamble^)



Possible Revlimid side effects in male

Reported by a pharmacist from United States on 2012-05-22

Patient: male

Reactions: White Blood Cell Count Decreased, Renal Disorder, Pneumonia

Adverse event resulted in: death

Drug(s) suspected as cause:
Revlimid



Possible Revlimid side effects in male

Reported by a physician from United States on 2012-05-21

Patient: male, weighing 84.9 kg (186.8 pounds)

Reactions: White Blood Cell Count Decreased, Platelet Count Decreased, Pancytopenia, Squamous Cell Carcinoma of Skin, Neutropenia, Multiple Myeloma

Drug(s) suspected as cause:
Revlimid
    Dosage: 10 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2008-12-01
    End date: 2009-01-01

Revlimid
    Dosage: 5 milligram
    Administration route: Oral
    Start date: 2009-06-01
    End date: 2009-01-01

Revlimid
    Dosage: 5 milligram
    Administration route: Oral
    Start date: 2009-11-12

Other drugs received by patient: Fluocinolone Acetonide; Meloxicam; Velcade; Doxazosin Mesylate; Loprox; Finasteride; Vitamin B6; Procrit; Aspirin; Ciclopirox; Sulfamethoxazole and Trimethoprim; Folic Acid; Prilosec; Vitamin B-12; Polyethylene Glycol



Possible Revlimid side effects in male

Reported by a physician from United States on 2012-05-18

Patient: male

Reactions: White Blood Cell Count Decreased

Drug(s) suspected as cause:
Revlimid
    Dosage: 10 milligram
    Administration route: Oral
    Start date: 2012-01-01
    End date: 2012-04-01

Revlimid
    Dosage: 25 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2011-04-01
    End date: 2012-03-29

Other drugs received by patient: Aredia; Dexamethasone; Coumadin; Velcade



Possible Revlimid side effects in male

Reported by a physician from United States on 2012-05-16

Patient: male

Reactions: White Blood Cell Count Decreased, Platelet Count Decreased

Drug(s) suspected as cause:
Revlimid

Other drugs received by patient: Vicodin; Flomax; Prilosec; Oxycodone HCL; Proamatine; Lyrica; Acyclovir



Possible Revlimid side effects in female

Reported by a physician from United States on 2012-05-07

Patient: female

Reactions: White Blood Cell Count Decreased, Convulsion

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Revlimid
    Dosage: 25 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2012-02-06

Revlimid
    Dosage: 15 milligram
    Administration route: Oral
    Start date: 2012-03-01

Other drugs received by patient: Antibiotics; Vitamin D; Aspirin; Zometa; Calcium



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017